GLP-1s drugs like Ozempic may actually boost fertility in men: study
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"GLP-1s drugs like Ozempic may actually boost fertility in men: study" is generating significant coverage in the Health category, with 2 articles from 2 distinct sources tracked by PULSE so far.
Outlets currently covering the story include ThePrint and Новости GxP. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 92d ago.
Quick answers
Why is "GLP-1s drugs like Ozempic may actually boost fertility in men: study" trending?
Because 2 independent news sources published 2 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (2)
- Obesity drugs likely to improve male fertility, says UK study ThePrint · 136d ago
- Testosterone levels normalise in 77% of men after obesity drug treatment, data show Новости GxP · 136d ago
Topics
Related trends
New weight loss drug proves twice as powerful as Ozempic’s highest dosage
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Lilly's Retatrutide Trounces Ozempic In Head-To-Head Study
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Retatrutide beats Ozempic on weight loss, blood sugar control, study says
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss
Eli Lilly reports that its new drug, retatrutide, achieved more than double the weight loss of Ozempic's highest approved dose in a head-to-head trial.
Women On GLP-1s Are Revealing The Side Effects And Experiences No One Told Them About
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Women On GLP-1s Are Revealing The Side Effects And Experiences No One Told Them About
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.